The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
Experts warn of undetected neurologic complications in young children as flu activity increases in the US. Learn more about the research findings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback